Results 151 to 160 of about 574,925 (310)
Expert Panel Consensus on Management of Advanced Cancer–Related Pain in Individuals With Opioid Use Disorder [PDF]
Jessica S. Merlin+10 more
openalex +1 more source
Research progress on the depth of anesthesia monitoring based on the electroencephalogram
Electroencephalogram (EEG) can noninvasive, continuous, and real‐time monitor the state of brain electrical activity, and the monitoring of EEG can reflect changes in the depth of anesthesia (DOA). The development of artificial intelligence can enable anesthesiologists to extract, analyze, and quantify DOA from complex EEG data.
Xiaolan He, Tingting Li, Xiao Wang
wiley +1 more source
US ED Opioid-Related Visits Increase, While Use of Medication for Opioid Use Disorder Undetectable, 2011–2016 [PDF]
Siri Shastry+3 more
openaire +2 more sources
Prolonged aura or status epilepticus? Unmasking a first‐time migraine attack
Epileptic Disorders, EarlyView.
Tiago Lerda Casaccia+6 more
wiley +1 more source
Cancer in pregnancy: FIGO Best practice advice and narrative review
Abstract Cancer during pregnancy is relatively rare. The incidence is underestimated due to the lack of international registries covering both high‐income and low‐ and middle‐income countries, and is expected to rise with increasing maternal age and increasing global adoption of cell‐free DNA testing for aneuploidy.
Surabhi Nanda+29 more
wiley +1 more source
Abstract Maternal substance use is a pressing public health issue that confers risk for maternal health, the parent‐infant relationship, and child development. Integrated interventions that jointly address maternal substance use and child development have shown promise for enhancing child outcomes.
Sophie Barriault+6 more
wiley +1 more source
NSSI is addictive in adolescents with depression disorders. It may be related to the decrease of serum beta‐endorphin concentration and the activation of brain reward system. ABSTRACT Background Nonsuicidal self‐injury (NSSI) in adolescents with depression disorders often exhibits addictive patterns, potentially linked to serum beta‐endorphin levels ...
Jie Li+6 more
wiley +1 more source
Lynn R Webster,1 Robert J Israel2 1PRA Health Sciences, Salt Lake City, UT, USA; 2Clinical and Medical Affairs, Salix Pharmaceuticals, Bridgewater, NJ, USA Purpose: An oral formulation of methylnaltrexone has been developed for treating opioid-induced ...
Webster LR, Israel RJ
doaj